Libra Review | Choose Better

You can view the original post here Literally millions of men have struggled with weight loss, and have had difficulty finding anything that really worked well for them. Diet and exercise are both critical components of a healthy lifestyle, but even if you’re observing a good diet and have regular exercise, you might still not be able to take off the weight you really want to. This is where the Zerona fat loss procedure can be extremely valuable and help you accomplish your objectives. Zerona targets those places on your body where fat is typically stored, and makes you look excessively bulky in those areas. If you’ve tried all the diets and pills, and found that none of those things really work for you, you are probably a good candidate for undergoing the Zerona procedure. What exactly is Zerona? The Zerona system makes use of a low-level laser technology which stimulates and emulsifies the stubborn fat cells in your body. This is considered a cold laser te...

  Pfizer exited neuroscience drug research years ago, but the company still found a way to add a new neuro drug to its portfolio. An FDA-approved migraine drug from partner Biohaven Pharmaceuticals now has marketing authorizations in Europe, enabling the pharmaceutical giant to start capturing a share of the fast-growing product. The two companies announced Wednesday that the European Commission has approved Biohaven drug rimegepant for both migraine prevention and the treatment of acute migraine pain. The European decisions match the approved indications for the drug in the U.S., where it is marketed under the name Nurtec. In Europe, the drug will be called Vydura. The approvals in Europe are also a win for Pfizer. Last November, the pharma giant inked a deal for the right to commercialize rimegepant globally, with the exception of the U.S. where Biohaven retains rights. Pfizer paid $500 million up front, a combination cash and stock. It’s also on the hook to pay New Hav...